- Home
- IGC vs EKSO Comparison
IGC vs EKSO Comparison
Compare IGC & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IGC | EKSO |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5M | 23.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IGC | EKSO |
|---|---|---|
| Price | $0.29 | $8.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.13 | ★ $9.50 |
| AVG Volume (30 Days) | 634.9K | ★ 5.9M |
| Earning Date | 02-17-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,106,000.00 | ★ $14,749,000.00 |
| Revenue This Year | $3.54 | N/A |
| Revenue Next Year | $15.12 | $54.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.25 | $2.73 |
| 52 Week High | $0.50 | $12.70 |
Technical Indicators
Market Signals| Indicator | IGC | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 54.20 |
| Support Level | $0.29 | $7.70 |
| Resistance Level | $0.30 | $9.11 |
| Average True Range (ATR) | 0.01 | 1.06 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 20.75 | 17.11 |
Price Performance
Historical ComparisonAbout IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.